Synthesis of 6-dialkylaminopyrimidine carboxamide analogues and their anti-tubercular properties
Open Access
- 18 October 2024
- journal article
- research article
- Published by Springer Nature in Medicinal Chemistry Research
- Vol. 33 (12) , 2491-2516
Abstract
Tuberculosis (TB) continues to be a threat to global health stability. Pyrimidine carboxamides have demonstrated potent anti-tubercular properties against clinical Mycobacterium tuberculosis, the causative agent of TB. Herein, we report a follow-up study on the synthesis of pyrimidine carboxamide molecular analogues and their anti-TB evaluation. In total, a library consisting of 37 new compounds is reported. Seven compounds (7b, 7d, 7m, 7p, 7q, 7aa, and 7ah) demonstrated excellent in vitro activities with MIC90 values below 1.00 µM. Apart from compound 7ah, compounds with improved aqueous solubility properties had lower anti-TB potency. Preliminary mode of action studies using bioluminescence assays indicate that the active compounds do not affect the integrity of mycobacterial DNA or the cell wall. The active compounds were also found to be bactericidal against replicating H37Rv Mtb strain.Keywords
All Related Versions
This publication has 37 references indexed in Scilit:
- Pyrimidine derivatives with antitubercular activityEuropean Journal of Medicinal Chemistry, 2022
- Exploration of 4-aminopyrrolo[2,3-d]pyrimidine as antitubercular agentsMolecular Diversity, 2022
- Mycobacterial Membrane Protein Large 3 (MmpL3) Inhibitors: A Promising Approach to Combat TuberculosisChemMedChem, 2021
- Potential drug–drug interactions between antiretroviral therapy and treatment regimens for multi-drug resistant tuberculosis: Implications for HIV care of MDR-TB co-infected individualsInternational Journal of Infectious Diseases, 2019
- Design and synthesis of novel pyrimidine derivatives as potent antitubercular agentsEuropean Journal of Medicinal Chemistry, 2019
- Comprehensive analysis of methods used for the evaluation of compounds against Mycobacterium tuberculosisTuberculosis, 2012
- Synthesis and biological evaluation of pyrimidine analogs of antimycobacterial purinesBioorganic & Medicinal Chemistry, 2010
- Central metabolism in Mycobacterium smegmatis during the transition from O2-rich to O2-poor conditions as studied by isotopomer-assisted metabolite analysisBiotechnology Letters, 2009
- Substituted benzyl-pyrimidines targeting thymidine monophosphate kinase of Mycobacterium tuberculosis: Synthesis and in vitro anti-mycobacterial activityBioorganic & Medicinal Chemistry, 2008
- Orally active factor Xa inhibitor: synthesis and biological activity of masked amidines as prodrugs of novel 1,4-diazepane derivativesBioorganic & Medicinal Chemistry, 2004